Obesity

3.4 Obesity




Introduction


Paediatric obesity is a major public health problem in both developed and developing countries. Obese children and adolescents may suffer from a host of co-morbidities, some of which are immediately apparent, whereas others act as warning signs of future disease. Obesity can be a serious, chronic, relapsing disease. It is a disorder of energy imbalance that arises as a consequence of a complex interaction between genetic, social, behavioural and environmental factors. Although investment in primary prevention is vital in curbing the epidemic, effective treatment of those children and adolescents who are currently obese is also needed to improve both their immediate and long-term health outcomes.




How is paediatric overweight and obesity defined?



Body mass index – a measure of total body fatness


Body mass index (BMI; weight/height2; kg/m2) is a simple measure of body fatness. BMI varies dramatically with age and sex during childhood and adolescence: it increases in the first year, falls during preschool years, and then rises once more into adolescence. The point at which BMI starts to increase again, between 4 and 7 years of age, is termed the point of ‘adiposity rebound’ (Figs 3.4.13.4.4).






Several countries have their own BMI-for-age growth charts that can be used clinically to chart an individual’s BMI and monitor changes over time. The World Health Organization has also developed BMI-for-age charts for international use for children aged 0–5 and 5–19 years (see Figs 3.4.13.4.4). Until further research helps establish the relation between BMI-for-age cut-points and health outcomes in childhood and adolescence, the decision as to which specific centile lines denote overweight and obesity in clinical settings ultimately remains arbitrary.






What are the complications of paediatric obesity?


The complications of obesity among children and adolescents may be immediate or may not manifest until the medium- to long-term. They affect many body systems, as outlined in Table 3.4.1.


Table 3.4.1 Potential obesity-associated complications in children and adolescents

































System Health problems
Psychosocial Social isolation and discrimination, decreased self-esteem, learning difficulties, body image disorder, bulimia
Medium and long term: poorer social and economic ‘success’, bulimia
Respiratory Obstructive sleep apnoea, asthma, poor exercise tolerance
Orthopaedic Back pain, slipped femoral capital epiphyses, tibia vara, ankle sprains, flat feet
Hepatobiliary Non-alcoholic fatty liver disease, gallstones
Reproductive Polycystic ovary syndrome, menstrual abnormalities
Cardiovascular Hypertension, adverse lipid profile (low HDL cholesterol, high triglycerides, high LDL cholesterol)
Medium and long term: increased risk of hypertension and adverse lipid profile in adulthood, increased risk of coronary artery disease in adulthood, left ventricular hypertrophy
Endocrine Hyperinsulinaemia, insulin resistance, impaired glucose tolerance, impaired fasting glucose, type 2 diabetes mellitus
Medium and long term: increased risk of type 2 diabetes mellitus and metabolic syndrome in adulthood
Neurological Benign intracranial hypertension
Skin Acanthosis nigricans, striae, intertrigo

HDL, high-density lipoprotein; LDL, low-density lipoprotein.



Complications during childhood and adolescence



Psychosocial complications


The most common consequences of obesity in childhood and adolescence are those related to psychosocial dysfunction and social isolation. In pre-adolescent children, physical appearance and athletic competence self-esteem are lower than in their normal weight peers, although global self-esteem appears to be preserved. In adolescent girls, excess weight is significantly related to body dissatisfaction, drive for thinness and bulimia. Cross-sectional studies of teenagers show an inverse relationship between weight and both global self-esteem and body-esteem. The pervasive, negative social messages associated with obesity in many communities may have a particular impact during adolescence.


There are differences in health-related quality of life between obese and non-obese children. In randomly sampled populations, the physical and social domains of health-related quality of life for obese children are lower than for non-overweight children. Severely obese patients have significantly reduced health-related quality of life compared with healthy children, having similar quality of life scores to children diagnosed with cancer.



image Clinical example



Trudy, a 13-year-old girl with obesity


Trudy presented to her general practitioner (GP) with a respiratory tract infection. Her mother commented incidentally that Trudy was concerned about her weight and was being teased at school. Indeed, she had left her previous school because of bullying and now it appeared to be starting afresh in the new school.


Trudy is an only child, with a good relationship with her parents and some peers. She is in good general health, apart from the weight gain. Several family members are obese (mother and three grandparents), her paternal grandfather has type 2 diabetes, and her maternal grandfather has hypercholesterolaemia and ischaemic heart disease. Trudy leads a sedentary lifestyle: she enjoys playing music, sewing, reading and talking on the phone. Trudy is driven to and from school each day and watches 3 hours of television per day. Her dietary intake includes skipping breakfast, full-cream milk, ‘something nice’ for morning and afternoon tea, buying food at the milk-bar in the afternoon, a daily intake of 500 mL of soft drink and free access to biscuits at home.


On examination, Trudy’s height was 161.5 cm (< 75th centile), weight 74.3 kg (> 97th centile), BMI 28.4 kg/m2 (> 95th centile for age; adult overweight range), waist circumference 89 cm (adult female ‘at significant risk of metabolic complications’ range) and waist : height ratio 0.55 (> 0.5, indicative of cardiometabolic risk). She was in mid-puberty, and had abdominal and upper thigh striae. Blood pressure was 120/80 mmHg. A fasting blood test showed a normal glucose (4.6 mmol/L; normal range 3.5–5.5), mild hyperinsulinaemia (115 pmol/L) and a lipid profile characteristic of central obesity: total cholesterol 5.3 mmol/L (normal range 2.6–5.5), high-density lipoprotein (HDL) cholesterol 0.8 mmol/L (normal > 0.9), triglycerides 1.9 mmol/L (normal range 0.6–1.7).









Aug 4, 2016 | Posted by in PEDIATRICS | Comments Off on Obesity

Full access? Get Clinical Tree

Get Clinical Tree app for offline access